Hemodynamic and Cardiac Effects of Nisoldipine in Ischemic Left Ventricular Dysfunction
- 28 Downloads
The use of calcium antagonists in patients with left ventricular dysfunction remains a controversial issue, largely because of evidence of reflex neurohormonal activation and of worsening of congestive heart failure symptoms during their administration [1–5]. However, the negative results observed with some calcium antagonists such as nifedipine or diltiazem [4, 5] are balanced by more promising observations with amlodipine and nisoldipine [6, 7]. In these studies, the calcium antagonists were well tolerated and there was evidence of an improvement in left ventricular ejection fraction or diastolic filling as well as in exercise capacity.
KeywordsMyocardial Perfusion Calcium Antagonist Peak Filling Rate Single Photon Emission Compute Tomography Data MIBI Uptake
Unable to display preview. Download preview PDF.
- 2.Packer M (1989) Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation 80: 59–67Google Scholar
- 4.Elkayam U, Amin J, Mehra A, Vasquez J, Weber L, Rahimtoola SH (1990) A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 82: 1954–1961PubMedCrossRefGoogle Scholar
- 5.Goldstein RD, Boccuzzi SJ, Cruess D, Nattel S (1991) The Adverse Experience Committee and the Multicenter Diltiazem Post-infarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 83: 52–60PubMedGoogle Scholar
- 6.Packer M, Nicod P, Khandheria BR et al (1991) Randomized, multicentre, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure (abs). J Am Coll Cardiol 17: 274AGoogle Scholar
- 7.The DEFIANT Research Group (1992) Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Eur Heart J 13: 1496–1505Google Scholar
- 16.Rousseau MF, Hanet C, Desager JP, Pouleur H (1987) Effects of long-term therapy with the association of nisoldipine and a beta-blocker on exercise tolerance and coronary hemodynamics in patients with stable angina: a comparison with mono-therapy. In: Hugenholtz PG, Meyer J (eds) Nisoldipine 1987. Springer, Berlin Heidelberg New York, pp 213–222Google Scholar
- 17.Frishman WH, Skolnick AE, Strom JA (1989) Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy. Circulation 80: 151–161Google Scholar
- 18.Rousseau MF, Gurné O, Benedict CR, van Eyll C, Pouleur H (1990) Effects of nisoldipine on the time-dependent changes in left ventricular function and neuro-humoral status in patients with ischemic heart disease. In: Lichtlen PR, Krayenbühl HP (eds) Aspects of nisoldipine. Symposium, 11th Congr European Society of Cardiology, Nice. Schattauer, Stuttgart, pp 69–83Google Scholar
- 19.Pouleur H, Rousseau MF (1988) Regional diastolic dysfunction in coronary artery disease: clinical and therapeutic implications. In: Grossman W, Lorell BH (eds) Diastolic relaxation of the heart. Martinus Nijhoff, Boston, pp 245–254Google Scholar
- 23.Bonow RO (1990) Regional left ventricular nonuniformity. Effects on left ventricular diastolic function in ischemic heart disease, hypertrophic cardiomyopathy, and the normal heart. Circulation 81: 54–65Google Scholar
- 29.Etingin OR, Hajjar DP (1990) Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue. Clin Res 66: 185–190Google Scholar